Answers are grounded in this paper and cite their sources.
Objective To investigate the impact of first-trimester subchorionic hematoma (SCH) on pregnancy outcomes in patients with recurrent spontaneous abortion (RSA), and to analyze the risk characteristics associated with SCH-related adverse pregnancy outcomes, with the aim of providing clinical evidence to inform pregnancy management and prognostic assessment in this high-risk population. Methods A retrospective cohort study was conducted. Clinical data were collected from RSA patients with early singleton pregnancies who were followed up at the Reproductive Immunology Clinic and the Department of Obstetrics of our hospital from January 2021 to January 2025. Patients were assigned to the SCH group or the non-SCH group according to the presence of SCH detected on first-trimester transvaginal ultrasonography. Baseline characteristics, pregnancy maintenance, adverse pregnancy outcomes, and late-pregnancy complications were compared between the two groups. Multivariate logistic regression analysis was performed to identify independent risk factors for adverse pregnancy outcomes in RSA patients. Results A total of 386 RSA patients were included, with 68 (17.62%) in the SCH group and 318 (82.38%) in the non-SCH group. No significant differences were observed between the two groups in age, body mass index, comorbidities, or number of previous miscarriages (all P > 0.05), indicating comparability. The incidence of vaginal bleeding and abdominal pain was significantly higher in the SCH group (P < 0.05). The rates of early miscarriage and overall adverse pregnancy outcomes were significantly higher, whereas the live birth rate was significantly lower, in the SCH group than in the non-SCH group (all P < 0.05). Stratified analysis suggested that larger hematoma volume and longer hematoma duration were associated with an increased risk of miscarriage in RSA patients. Multivariate logistic regression analysis identified first-trimester SCH as an independent risk factor for adverse pregnancy outcomes in RSA patients (OR = 2.874, 95% CI: 1.526–5.412, P = 0.001). Conclusion In this cohort of RSA patients, first-trimester SCH was associated with an increased risk of early miscarriage and adverse pregnancy outcomes and a reduced live birth rate, and it emerged as an independent risk factor for poor pregnancy prognosis. For RSA patients with coexisting SCH, enhanced pregnancy surveillance and individualized management may be considered to help improve pregnancy outcomes.
No takes yet. Share an insight, caveat, or question.
Fan et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: